Invest Now ! 
WEED, Inc. (BUDZ) is a publicly listed, publicly traded, fully reporting, PCAOB audited, Sarbanes-Oxley compliant corporation.

WEED, Inc. is a multi-national, multi-faceted, vertically integrated world-class cannabis organization focused on the development and application of strain and disease specific cannabis and hemp-derived compounds for the treatment of humans and animals. WEED, Inc.’s strategy is to develop, acquire and control the intellectual properties of patents, trademarks, copyrights, licenses, and cannabis-based products and create recognized brand names in the cannabis and hemp sectors with national and international distribution channels.

WEED, Inc. is structured as a holding company doing business through its divisions, wholly owned subsidiaries, and strategically placed collaborative partners to achieve and promote the WEED, Inc. brand.

WEED, Inc. is fully dedicated to its global goal of producing, marketing and distributing treatments, medical therapies and products utilizing the full spectrum of the Cannabaceae plant family.

Sangre BioSciences

Sangre BioSciences is currently in the process of conducting a
comprehensive Cannabis Genome Study to complete a global genomic classification of the cannabis plant genus. Sangre BioSciences is focused on a genomics-based cannabis
breeding program that will produce new, genetically enhanced strains of cannabis that express the desired
plant characteristics for strain specific and disease specific treatments and therapies for both humans and animals.

WEED Australia Ltd.

WEED Australia Ltd.’s corporate strategy is to become a leader in cannabis and hemp research and development. To support this goal WEED Australia Ltd. has assembled
a highly qualified team of wellrespected Ph.D.’s, scientists, researchers and business experts with the goal of establishing a domestic and export industry.

WEED Israel Cannabis Ltd.

WEED, Inc. intends to enter into an exclusive license and assignment agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Israel. The agreement is for five patents, technology and know-how relating to formulations for the administration and delivery of cannabinoid compounds. These patents were developed by Prof. Elka Touitou at the Hebrew University of Jerusalem. WEED Israel Cannabis Ltd. is currently obtaining licenses to grow, cultivate, process, extract, and manufacture cannabis derived products for the Israeli domestic and broader international markets.

WEED Hong Kong Limited

WEED Hong Kong Limited is a special purpose holding company for the development of the company’s patents, trademarks, copyrights and intellectual property for the company and brands of WEED Inc. on a global basis. Glenn E Martin, Director,
President, CEO. Nicole Marie Breen, Director and company Treasurer. Ed Lehman, of Lehman, Le and Xu Corporate Services Limited, is appointed the corporate secretary. Registered office: Lehman, Lee and Xu. Suite 3313, Tower One, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong.


Be the first to receive the latest Industry and WEED INC. News & Updates.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram